Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Statistics

Total Valuation

XERS has a market cap or net worth of $792.77 million. The enterprise value is $1.00 billion.

Market Cap	792.77M
Enterprise Value	1.00B

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

XERS has 160.16 million shares outstanding. The number of shares has increased by 8.11% in one year.

Current Share Class	160.16M
Shares Outstanding	160.16M
Shares Change (YoY)	+8.11%
Shares Change (QoQ)	+2.25%
Owned by Insiders (%)	3.89%
Owned by Institutions (%)	41.61%
Float	153.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.33
Forward PS	4.05
PB Ratio	-22.57
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.72

Current Ratio	1.72
Quick Ratio	1.10
Debt / Equity	n/a
Debt / EBITDA	98.08
Debt / FCF	n/a
Interest Coverage	-0.53

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-3.14%
Return on Invested Capital (ROIC)	-4.15%
Return on Capital Employed (ROCE)	-7.44%
Revenue Per Employee	$564,850
Profits Per Employee	-$114,406
Employee Count	394
Asset Turnover	0.68
Inventory Turnover	0.85

Taxes

Income Tax	-2.58M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +181.25% in the last 52 weeks. The beta is 0.91, so XERS's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	+181.25%
50-Day Moving Average	4.66
200-Day Moving Average	3.51
Relative Strength Index (RSI)	58.18
Average Volume (20 Days)	2,328,752

Short Selling Information

The latest short interest is 17.23 million, so 10.76% of the outstanding shares have been sold short.

Short Interest	17.23M
Short Previous Month	19.05M
Short % of Shares Out	10.76%
Short % of Float	11.19%
Short Ratio (days to cover)	4.79

Income Statement

In the last 12 months, XERS had revenue of $222.55 million and -$45.08 million in losses. Loss per share was -$0.30.

Revenue	222.55M
Gross Profit	182.96M
Operating Income	-16.39M
Pretax Income	-59.08M
Net Income	-45.08M
EBITDA	-4.33M
EBIT	-16.39M
Loss Per Share	-$0.30

Balance Sheet

The company has $58.44 million in cash and $268.75 million in debt, giving a net cash position of -$210.31 million or -$1.31 per share.

Cash & Cash Equivalents	58.44M
Total Debt	268.75M
Net Cash	-210.31M
Net Cash Per Share	-$1.31
Equity (Book Value)	-35.13M
Book Value Per Share	-0.23
Working Capital	68.42M

Cash Flow

In the last 12 months, operating cash flow was -$26.71 million and capital expenditures -$717,000, giving a free cash flow of -$27.43 million.

Operating Cash Flow	-26.71M
Capital Expenditures	-717,000
Free Cash Flow	-27.43M
FCF Per Share	-$0.17

Margins

Gross margin is 82.21%, with operating and profit margins of -7.37% and -20.25%.

Gross Margin	82.21%
Operating Margin	-7.37%
Pretax Margin	-21.41%
Profit Margin	-20.25%
EBITDA Margin	-1.95%
EBIT Margin	-7.37%
FCF Margin	n/a

Dividends & Yields

XERS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.11%
Shareholder Yield	-8.11%
Earnings Yield	-5.69%
FCF Yield	-3.46%

Analyst Forecast

The average price target for XERS is $6.25, which is 26.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.25
Price Target Difference	26.26%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	19.68%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XERS has an Altman Z-Score of -1.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.48
Piotroski F-Score	3